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Abstract 
The application of Next-Generation Sequencing for studying the genetics of papillary thyroid carcinomas (PTC) has 
recently revealed new somatic mutations and gene fusions as potential new tumor-initiating events in patients without 
any known driver lesion. Gene and miRNA expression analyses defined clinically relevant subclasses correlated to 
tumor progression. In addition, it has been shown that tumor driver mutations in BRAF, and RET rearrangements - 
altogether termed "BRAF-like" carcinomas - have a very similar expression pattern and constitute a distinct category. 
Conversely, "RAS-like" carcinomas have a different genomic, epigenomic, and proteomic profile. These findings 
justify the need to reconsider PTC classification schemes.  
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